Study guide

5.4 BPD, Apnea & Chronic Neonatal Lung Disease

NBRC RRT-NPS Neonatal/Pediatric Specialist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Neonatal and Pediatric Patient Assessment

1.1 Maternal, Obstetric & Perinatal History 1.2 Fetal Surveillance & Antepartum Diagnostics 1.3 Gestational Age & Baseline Neonatal Examination 1.4 Apgar, Respiratory Distress & Thoracic Assessment 1.5 Pediatric Assessment Triangle & Vital Signs 1.6 Neurologic Assessment, Respiratory Failure & Triage

2 Chapter 2: Diagnostic Evaluation & Gas Exchange Monitoring

2.1 Pulse Oximetry, Pre/Postductal & Transcutaneous Monitoring 2.2 Capnography, Waveforms & Dead-Space Evaluation 2.3 Arterial & Capillary Blood-Gas Sampling 2.4 Umbilical Lines, Acid-Base & Laboratory Evaluation 2.5 Chest Imaging & Airway Radiography 2.6 Pulmonary Function, Bronchoscopy & Specimen Diagnostics

3 Chapter 3: Airway Management & Secretion Clearance

3.1 Pediatric Airway Anatomy & ETT Sizing 3.2 Cuffed Airways, Intubation & Difficult-Airway Management 3.3 Tracheostomy Devices & Routine Care 3.4 Tracheostomy Emergencies, Speaking & Decannulation 3.5 Airway Suctioning Technique & Safety 3.6 Airway Clearance, Home Care & Discharge Planning

4 Chapter 4: Pharmacology & Medical Gas Therapy

4.1 Aerosol Physics & Delivery Devices 4.2 Respiratory & Systemic Pharmacology 4.3 Oxygen Interfaces & Delivery Systems 4.4 Oxygen Blenders, Targets & Toxicity 4.5 HFNC Physiology, Sizing & Flow 4.6 HFNC Indications, Monitoring & Escalation

5 Chapter 5: Shared Neonatal & Pediatric Pulmonary Disorders

5.1 Neonatal RDS Pathophysiology & Management 5.2 TTN, Pneumonia & the Neonatal Differential 5.3 Meconium Aspiration & PPHN 5.4 BPD, Apnea & Chronic Neonatal Lung Disease 5.5 Bronchiolitis, Croup & Epiglottitis 5.6 Asthma, Cystic Fibrosis & Foreign-Body Aspiration

6 Chapter 6: Resuscitation, Emergency Protocols & Patient Safety

6.1 NRP Cord Management, Initial Steps & Ventilation 6.2 NRP Corrective Steps, Compressions & Medications 6.3 PALS Assessment, CPR & Cardiac Arrest 6.4 PALS Dysrhythmia & Shock Management 6.5 Neonatal & Pediatric Transport 6.6 Patient Safety, Teamwork & Family-Centered Care

7 Chapter 7: Noninvasive & Conventional Mechanical Ventilation

7.1 Bubble CPAP & Neonatal NIV 7.2 Pediatric NIV, Interfaces & Failure Recognition 7.3 Conventional Ventilation Physics & Modes 7.4 Initial Settings & ABG-Guided Titration 7.5 Ventilator Scalars & Loops 7.6 Ventilator Dyssynchrony & Troubleshooting 7.7 Weaning Readiness & Spontaneous Breathing Trials 7.8 Extubation & Post-Extubation Airway Risk

8 Chapter 8: High-Frequency Ventilation & Advanced Modes

8.1 HFOV Mechanics & Gas Transport 8.2 HFOV Controls & Clinical Management 8.3 HFJV Circuit & Controls 8.4 HFJV Servo Pressure & Clinical Indications 8.5 NAVA, Edi & Proportional Support 8.6 APRV in Pediatric Respiratory Failure

9 Chapter 9: Specialty Inhaled Gases & Exogenous Surfactant Therapy

9.1 Inhaled Nitric Oxide: Mechanism, Indications & Dose 9.2 Inhaled Nitric Oxide: Toxicity, Monitoring & Weaning 9.3 Heliox Physics & Delivery 9.4 Volatile Anesthetic & Subambient Gas Therapy 9.5 Surfactant Biology, Products & Dosing 9.6 Surfactant Administration & Response

10 Chapter 10: Pediatric ARDS & Parenchymal Critical Illness

10.1 PALICC-2 Diagnosis & Severity 10.2 PALICC-2 NIV & Possible PARDS 10.3 PARDS Lung-Protective Ventilation 10.4 PARDS Refractory Hypoxemia & Adjuncts 10.5 PIE & Pneumothorax Recognition 10.6 Thoracic Decompression & Chest Drains

11 Chapter 11: Congenital Heart Disease & Hemodynamic Management

11.1 Left-to-Right Shunts & Qp/Qs Physiology 11.2 Acyanotic Lesions & Respiratory Management 11.3 Cyanotic Lesions & the Five Ts 11.4 Ductal Dependence, PGE1 & the Hyperoxia Test 11.5 Single-Ventricle Physiology & Staged Palliation 11.6 Gas Balancing, Hemodynamics & NIRS

12 Chapter 12: Advanced Critical Care: ECMO, Neurotrauma & Palliative Care

12.1 ECMO Candidacy & Modality 12.2 ECMO Circuit, Lung Rest & Anticoagulation 12.3 Neurotrauma, ICP & Ventilation 12.4 Neonatal Therapeutic Hypothermia & Respiratory Care 12.5 Death by Neurologic Criteria: Examination & Apnea Testing 12.6 DNC Timing, Ancillary Testing, Palliation & Donation

5.4 BPD, Apnea & Chronic Neonatal Lung Disease

Key Takeaways Explain This Topic AI

The Jensen evidence-based definition grades BPD at 36 weeks PMA by support mode: Grade 1 is nasal cannula at 2 L/min or less, Grade 2 is higher-flow cannula or noninvasive pressure, and Grade 3 is invasive ventilation.

Modern BPD reflects arrested alveolar and pulmonary vascular development with heterogeneous airway resistance and risk of pulmonary hypertension.

Long-term management integrates individualized respiratory support, nutrition and growth, aspiration assessment, development, caregiver competency, and discharge readiness.

Last updated: September 2026

  • 5.4 BPD, Apnea & Chronic Neonatal Lung Disease
  • Bronchopulmonary Dysplasia, Apnea & Chronic Lung Disease

Bronchopulmonary dysplasia is a chronic respiratory-support phenotype in infants born very preterm. Modern disease reflects arrested alveolar and pulmonary vascular development superimposed on oxygen exposure, ventilation, infection, inflammation, and growth failure. The result is fewer, larger alveoli; reduced gas-exchange surface; abnormal vascular growth; heterogeneous resistance; and vulnerability to pulmonary hypertension.

Evidence-based severity at 36 weeks PMA

For infants born before 32 weeks, the Jensen evidence-based definition classifies BPD by respiratory support at 36 weeks postmenstrual age, regardless of the oxygen concentration:

  • Grade Respiratory support at 36 weeks PMA
  • Grade 1 Nasal cannula at 2 L/min or less
  • Grade 2 Nasal cannula above 2 L/min or noninvasive positive airway pressure
  • Grade 3 Invasive mechanical ventilation

An infant on 3 L/min HFNC is Grade 2 under this definition, even if FiO2 is 0.30 or higher. Do not blend older oxygen-based NIH categories with the Jensen grades. Always identify which definition a question supplies.

Clinical phenotype and evaluation

Infants may have tachypnea, retractions, wheeze, prolonged exhalation, carbon-dioxide retention, feeding fatigue, poor growth, and episodic desaturation. Evaluate airway obstruction, atelectasis, infection, aspiration, anemia, fluid status, and pulmonary hypertension rather than attributing every deterioration to BPD. Echocardiography screens for pulmonary hypertension and ventricular function; gas trends and growth trajectory help determine adequacy of support.

Respiratory and multidisciplinary management

Use the lowest effective oxygen concentration while meeting the individualized saturation range, especially when pulmonary hypertension is present.

In established severe BPD, a slower ventilator rate, longer inspiratory time, adequate expiratory time, and sufficient tidal volume may be needed for heterogeneous lungs; follow pressure, volume, and gas-exchange trends rather than one universal setting.

Treat bronchospasm only when a bronchodilator response is demonstrated. Diuretics may help selected infants with pulmonary edema but require electrolyte and renal monitoring.

Optimize nutrition, growth, immunization, aspiration evaluation, development, and caregiver education.

Before discharge, verify oxygen and ventilator equipment, emergency tracheostomy or airway supplies when applicable, caregiver competency, follow-up, and a written escalation plan.

Apnea of prematurity results from immature respiratory control and is diagnosed after excluding infection, seizures, temperature disturbance, anemia, metabolic disease, and airway obstruction. Caffeine reduces apnea and supports extubation in appropriate preterm infants. A new apnea pattern in a previously stable infant is a clinical change that requires evaluation, not an automatic caffeine dose increase.

  • NPS Exam Traps
  • Exam Trap 1: Aggressive Normalization of PaCO2 in BPD

In an infant with established Grade 2 or 3 BPD, arterial blood gas often demonstrates a PaCO 2 \text{PaCO}_2 PaCO 2 ​ of 55 to 65 mmHg 55\text{ to }65\text{ mmHg} 55 to 65 mmHg with a normal or slightly low pH \text{pH} pH ( 7.32 to 7.36 7.32\text{ to }7.36 7.32 to 7.36 ) and a compensatory elevated bicarbonate ( 28 to 32 mEq/L 28\text{ to }32\text{ mEq/L} 28 to 32 mEq/L ). Do not increase ventilator rate or tidal volume to force the PaCO 2 \text{PaCO}_2 PaCO 2 ​ down to 40 mmHg. Aggressive hyperventilation causes volutrauma, barotrauma, and metabolic alkalosis, halting alveolar growth.

Exam Trap 2: Chronic Furosemide Complications

When an infant with BPD receives chronic daily furosemide without potassium supplementation, watch for two classic board exam traps: hypokalemic hypochloremic metabolic alkalosis on blood gas analysis, and nephrocalcinosis (renal medullary calcifications) or bone fractures on abdominal/chest imaging.

Deterioration and Discharge Cross-Check

A new oxygen requirement, rising carbon dioxide, feeding intolerance, or increased work of breathing in an infant with BPD is not automatically “baseline chronic lung disease.” Reassess tube or cannula position, secretion burden, atelectasis, infection, aspiration, anemia, fluid overload, airway malacia, pulmonary hypertension, and cardiac function. Compare with the infant’s established trend and response to bronchodilator or diuretic therapy rather than escalating every medication empirically.

Apnea in a preterm infant is a diagnosis of exclusion when the pattern is new or worsening. Check temperature, glucose, infection, anemia, reflux or aspiration, seizures, medication exposure, and airway obstruction. Document whether events include central pause, obstructive effort, bradycardia, desaturation, stimulation, or ventilation. Caffeine supports selected infants with apnea of prematurity, but dose changes follow weight, timing, serum concentration when indicated, and the neonatal plan.

Discharge planning tests the entire respiratory system around the child. Caregivers should demonstrate oxygen or ventilator setup, alarm response, suction, medication delivery, emergency bagging, and when to call emergency services. Confirm backup power and gas, travel calculations, equipment vendor support, smoke-free housing, safe sleep, feeding and aspiration plan, follow-up, immunoprophylaxis eligibility, and a written escalation pathway. An observed rooming-in period or structured competency checklist may reveal gaps before the infant leaves monitored care.